Losartan Potassium Tablets, 100 Mg
Product Images NDC 43353-299
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 100 Mg (NDC 43353-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 (Figure1)
Figure 2 (Figure2)
Figure 3 (Figure3)
This appears to be a chart or graph displaying results of a study evaluating the effects of two medications, Losartan and Atenolol, on the incidence of stroke in different demographic subgroups. The primary endpoint was a composite of fatal and non-fatal stroke events. The chart shows the number of events and hazard ratios for each subgroup, including age, gender, race, diabetes, and history of cardiovascular disease. Symbols on the chart are proportional to sample size. There is not enough context to determine the overall results or conclusions of the study.*
Figure 4.jpg (Figure4)
This is a partial data table with some numerical values and drug names. The number 80 appears to be related to patients experiencing an "event." There is also a percentage value of "Risk Reduction = 16.1%". The drug names mentioned in the table are Losartan Potassium and Placebo. There are some numbers (022, 12, 24, 48) but it is unclear what they refer to without more context.*
Losartan Potassium, Usp (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.